Issue 7, 2013

Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death

Abstract

Two hybrid compounds comprising an antimetastatic ruthenium–arene fragment tethered to an indazole-3-carboxylic acid derivative that inhibits aerobic glycolysis in cancer cells have been prepared and evaluated in a variety of cancer cell lines, including highly relevant human glioblastoma cells, with an apparent synergistic action between the two components observed.

Graphical abstract: Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death

Supplementary files

Article information

Article type
Communication
Submitted
24 Aug 2012
Accepted
21 Nov 2012
First published
22 Nov 2012

Dalton Trans., 2013,42, 2347-2350

Organometallic anticancer agents that interfere with cellular energy processes: a subtle approach to inducing cancer cell death

A. A. Nazarov, D. Gardini, M. Baquié, L. Juillerat-Jeanneret, T. P. Serkova, E. P. Shevtsova, R. Scopelliti and P. J. Dyson, Dalton Trans., 2013, 42, 2347 DOI: 10.1039/C2DT31936E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements